Balance Sheet Veracyte, Inc.

Equities

VCYT

US92337F1075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
33.80 ^USD	+2.33%		+8.72%	-19.71%

Apr. 13	Jefferies Initiates Veracyte at Buy With $45 Price Target	MT
Mar. 16	Veracyte names Kevin Haas as chief development and technology officer	RE

b3cfe797b431a4c0ae2.sqDDm8SDvfnJs76TlI3dQ_XTNOSfsPNlairjvFAwnUw.4tq0z63A65Gb5_ai7sqUM42gAJ7e8bksJFPO4yZlsHjn-I71obXikYPK7w

Published financial data: VERACYTE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	220M	297M	361M	446M	517M
Total Revenues	220M	297M	361M	446M	517M
Cost of Goods Sold, Total	74.4M	102M	113M	136M	144M
Gross Profit	145M	195M	248M	310M	373M
Selling General & Admin Expenses, Total	158M	171M	192M	199M	226M
R&D Expenses	29.84M	40.6M	53.8M	69.29M	70.81M
Amortization of Goodwill and Intangible Assets - (IS)	15.98M	21.35M	20.57M	14.85M	13.15M
Other Operating Expenses, Total	204M	233M	266M	283M	310M
Operating Income	-58.99M	-37.63M	-17.93M	26.78M	62.99M
Interest Expense, Total	-241K	-198K	-15K	-2K	-1K
Interest And Investment Income	135K	1.97M	7.34M	11.15M	12.72M
Net Interest Expenses	-106K	1.77M	7.33M	11.15M	12.72M
Currency Exchange Gains (Loss)	-1.08M	197K	723K	-2.04M	3.97M
Other Non Operating Income (Expenses)	1.44M	2.68M	1.13M	495K	436K
EBT, Excl. Unusual Items	-58.74M	-32.97M	-8.75M	36.38M	80.12M
Merger & Related Restructuring Charges	-22.1M	-	-	-5.1M	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-6.71M
Asset Writedown	-	-3.3M	-68.35M	-3.37M	-20.5M
Other Unusual Items	-810K	-154K	483K	-2.17M	15.3M
EBT, Incl. Unusual Items	-81.65M	-36.43M	-76.61M	25.74M	68.2M
Income Tax Expense	-6.09M	133K	-2.21M	1.61M	1.85M
Earnings From Continuing Operations	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Net Income to Company	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Net Income - (IS)	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Net Income to Common Incl Extra Items	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Net Income to Common Excl. Extra Items	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Per Share Items
Net EPS - Basic	-1.11	-0.51	-1.02	0.32	0.84
Basic EPS - Continuing Operations	-1.11	-0.51	-1.02	0.32	0.84
Basic Weighted Average Shares Outstanding	67.89M	71.55M	72.64M	76.48M	78.58M
Net EPS - Diluted	-1.11	-0.51	-1.02	0.31	0.82
Diluted EPS - Continuing Operations	-1.11	-0.51	-1.02	0.31	0.82
Diluted Weighted Average Shares Outstanding	67.89M	71.55M	72.64M	78.16M	80.57M
Normalized Basic EPS	-0.54	-0.29	-0.08	0.3	0.64
Normalized Diluted EPS	-0.54	-0.29	-0.08	0.29	0.62
Supplemental Items
EBITDA	-39.4M	-11.7M	9.26M	50.24M	84.4M
EBITA	-43.01M	-16.27M	2.64M	41.58M	76.19M
EBIT	-58.99M	-37.63M	-17.93M	26.78M	62.99M
EBITDAR	-34.34M	-5.88M	17.37M	60.67M	103M
Total Revenues (As Reported)	220M	297M	361M	446M	517M
Effective Tax Rate - (Ratio)	7.45	-0.37	2.88	6.24	2.71
Current Domestic Taxes	63K	426K	1.52M	1.81M	2.31M
Current Foreign Taxes	54K	134K	193K	22K	114K
Total Current Taxes	117K	560K	1.71M	1.84M	2.43M
Deferred Domestic Taxes	-4.03M	118K	-90K	-230K	-580K
Deferred Foreign Taxes	-2.17M	-545K	-3.83M	-	-
Total Deferred Taxes	-6.2M	-427K	-3.92M	-230K	-580K
Normalized Net Income	-36.71M	-20.61M	-5.47M	22.74M	50.07M
Interest on Long-Term Debt	241K	198K	15K	2K	1K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	7.21M	6.14M	5.42M	6.28M	5.56M
Selling and Marketing Expenses	79.84M	97.56M	101M	95.43M	100M
General and Administrative Expenses	78.44M	67.25M	82.1M	92.9M	115M
Research And Development Expense From Footnotes	29.84M	43.9M	57.3M	69.29M	70.81M
Net Rental Expense, Total	5.06M	5.82M	8.11M	10.44M	19.03M
Imputed Operating Lease Interest Expense	614K	533K	69.89K	5.26K	3.35K
Imputed Operating Lease Depreciation	4.44M	5.28M	8.04M	10.43M	19.03M
Stock-Based Comp., COGS (Total)	640K	1.05M	1.78M	2.32M	2.29M
Stock-Based Comp., R&D Exp. (Total)	4.64M	6M	5.28M	7.51M	7.92M
Stock-Based Comp., S&M Exp. (Total)	4.39M	5.94M	9.59M	6.9M	8.32M
Stock-Based Comp., G&A Exp. (Total)	12.85M	13.74M	16.5M	19.52M	25.08M
Total Stock-Based Compensation	22.52M	26.73M	33.14M	36.25M	43.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	173M	154M	216M	239M	363M
Short Term Investments	-	24.6M	-	50.35M	50.31M
Total Cash And Short Term Investments	173M	179M	216M	289M	413M
Accounts Receivable, Total	41.46M	44.02M	40.38M	46.52M	44.66M
Other Receivables	-	-	4.7M	4.3M	-
Total Receivables	41.46M	44.02M	45.08M	50.82M	44.66M
Inventory	11.22M	14.29M	16.13M	21.75M	20.55M
Prepaid Expenses	17.22M	11.47M	7.96M	10.25M	10.28M
Restricted Cash	-	-	-	-	-
Total Current Assets	243M	249M	286M	372M	488M
Gross Property Plant And Equipment	52.62M	56.84M	63.72M	111M	102M
Accumulated Depreciation	-21.48M	-25.98M	-32.86M	-39.39M	-43.48M
Net Property Plant And Equipment	31.14M	30.86M	30.86M	71.14M	58.79M
Goodwill	708M	696M	703M	746M	767M
Other Intangibles, Total	203M	175M	88.59M	102M	89.15M
Other Long-Term Assets, Total	2.95M	6.17M	6.85M	8.52M	2.55M
Total Assets	1.19B	1.16B	1.11B	1.3B	1.41B
Liabilities
Accounts Payable, Total	12.36M	11.91M	12.94M	8.63M	4.59M
Accrued Expenses, Total	39.48M	37.77M	38.43M	43.83M	48.8M
Current Portion of Long-Term Debt	1.13M	-	-	-	-
Current Portion of Leases	3.63M	4.07M	5.1M	7.5M	4.05M
Unearned Revenue Current, Total	4.65M	2.61M	2.01M	1.67M	1.16M
Other Current Liabilities	2.91M	6.25M	2.76M	17M	1.33M
Total Current Liabilities	64.15M	62.61M	61.24M	78.63M	59.94M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	14.7M	11.05M	7.62M	43.24M	35.6M
Unearned Revenue Non Current	343K	-	-	-	-
Deferred Tax Liability Non Current	5.59M	4.53M	734K	1.23M	646K
Other Non Current Liabilities	6.53M	3.03M	1.2M	972K	257K
Total Liabilities	91.31M	81.22M	70.8M	124M	96.44M
Common Stock, Total	71K	72K	73K	78K	79K
Additional Paid In Capital	1.47B	1.5B	1.54B	1.66B	1.7B
Retained Earnings	-357M	-394M	-468M	-444M	-378M
Comprehensive Income and Other	-15.08M	-31.35M	-24.02M	-36.09M	-8.21M
Total Common Equity	1.1B	1.08B	1.04B	1.18B	1.31B
Total Equity	1.1B	1.08B	1.04B	1.18B	1.31B
Total Liabilities And Equity	1.19B	1.16B	1.11B	1.3B	1.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	71.22M	72.15M	75.07M	77.94M	79.46M
ECS Total Common Shares Outstanding	71.12M	71.96M	73.26M	77.77M	79.36M
Book Value / Share	15.42	14.94	14.25	15.12	16.5
Tangible Book Value	186M	204M	253M	328M	453M
Tangible Book Value Per Share	2.61	2.84	3.45	4.22	5.71
Total Debt	19.45M	15.12M	12.73M	50.74M	39.65M
Net Debt	-154M	-164M	-204M	-239M	-373M
Debt Equivalent Oper. Leases	40.44M	46.53M	64.9M	83.5M	152M
Account Code - Inventory Valuation	3	-	6	6	6
Inventories - Others	11.22M	14.29M	16.13M	21.75M	20.55M
Machinery, Total	22.35M	26.71M	33.81M	44.73M	46.44M
Full Time Employees	761	787	815	824	755
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-75.56M	-36.56M	-74.4M	24.14M	66.35M
Depreciation & Amortization - CF	3.61M	4.57M	6.62M	8.66M	8.22M
Amortization of Goodwill and Intangible Assets - (CF)	15.98M	21.35M	20.57M	14.8M	13.2M
Depreciation & Amortization, Total	19.59M	25.93M	27.19M	23.46M	21.42M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	206K	271K	202K	6.72M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-3.27M
Asset Writedown & Restructuring Costs	-	3.32M	68.35M	3.37M	20.5M
Stock-Based Compensation (CF)	22.52M	26.73M	33.14M	36.25M	43.6M
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-2.39M	4.29M	-6.16M	9M	-16.72M
Change In Accounts Receivable	-8.57M	-4.5M	3.89M	-6.4M	-708K
Change In Inventories	-1.46M	-3.01M	-1.69M	-5.87M	-2.86M
Change In Accounts Payable	5.16M	152K	-134K	-4.3M	-1.04M
Change in Other Net Operating Assets	9.1M	-9.03M	-6.22M	-4.74M	2.31M
Cash from Operations	-31.62M	7.54M	44.22M	75.1M	136M
Capital Expenditure	-5.38M	-8.55M	-9.96M	-11.29M	-9.68M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-737M	-	-	5.01M	-
Divestitures	-	-	-	-	-2.84M
Investment in Marketable and Equity Securities, Total	3M	-20.84M	25.07M	-50M	3.31M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-739M	-29.39M	15.11M	-56.28M	-9.21M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-1.28M	-	-	-
Total Debt Repaid	-	-1.28M	-	-	-
Issuance of Common Stock	605M	7.94M	9.58M	19.99M	14.08M
Repurchase of Common Stock	-9.03M	-3.17M	-6.74M	-10.59M	-18.3M
Other Financing Activities, Total	-	-	-	-4.5M	-
Cash from Financing	596M	3.49M	2.84M	4.9M	-4.22M
Foreign Exchange Rate Adjustments	-1.51M	-592K	163K	-424K	719K
Net Change in Cash	-176M	-18.95M	62.33M	23.3M	124M
Supplemental Items
Cash Interest Paid	9K	9K	-	-	-
Cash Income Tax Paid (Refund)	112K	570K	1.7M	2.24M	3.64M
Levered Free Cash Flow	327K	15.78M	37.36M	66.49M	86.8M
Unlevered Free Cash Flow	477K	15.9M	37.37M	66.49M	86.8M
Change In Net Working Capital	-612K	4.69M	1.79M	-1.34M	7.91M
Net Debt Issued / Repaid	-	-1.28M	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-4.48	-2.01	-0.99	1.39	2.91
Return on Total Capital	-4.76	-2.13	-1.04	1.47	3.06
Return On Equity %	-9.96	-3.37	-7.02	2.17	5.34
Return on Common Equity	-9.96	-3.37	-7.02	2.17	5.34
Margin Analysis
Gross Profit Margin %	66.11	65.74	68.73	69.48	72.16
SG&A Margin	72.11	57.54	53.1	44.59	43.75
EBITDA Margin %	-17.95	-3.95	2.56	11.27	16.32
EBITA Margin %	-19.59	-5.49	0.73	9.33	14.73
EBIT Margin %	-26.87	-12.69	-4.97	6.01	12.18
Income From Continuing Operations Margin %	-34.42	-12.33	-20.61	5.41	12.83
Net Income Margin %	-34.42	-12.33	-20.61	5.41	12.83
Net Avail. For Common Margin %	-34.42	-12.33	-20.61	5.41	12.83
Normalized Net Income Margin	-16.72	-6.95	-1.51	5.1	9.68
Levered Free Cash Flow Margin	0.15	5.32	10.35	14.92	16.78
Unlevered Free Cash Flow Margin	0.22	5.36	10.35	14.92	16.78
Asset Turnover
Asset Turnover	0.27	0.25	0.32	0.37	0.38
Fixed Assets Turnover	9.15	9.57	11.7	8.74	7.96
Receivables Turnover (Average Receivables)	7.33	6.94	8.56	10.26	11.34
Inventory Turnover (Average Inventory)	9.37	7.96	7.42	7.18	6.81
Short Term Liquidity
Current Ratio	3.79	3.97	4.66	4.73	8.15
Quick Ratio	3.35	3.56	4.27	4.33	7.63
Operating Cash Flow to Current Liabilities	-0.49	0.12	0.72	0.96	2.27
Days Sales Outstanding (Average Receivables)	49.82	52.61	42.66	35.68	32.18
Days Outstanding Inventory (Average Inventory)	38.96	45.85	49.17	50.94	53.62
Average Days Payable Outstanding	34.88	42.33	39.53	27.87	16.91
Cash Conversion Cycle (Average Days)	53.89	56.13	52.3	58.75	68.89
Long Term Solvency
Total Debt/Equity	1.77	1.41	1.22	4.31	3.03
Total Debt / Total Capital	1.74	1.39	1.2	4.14	2.94
LT Debt/Equity	1.34	1.03	0.73	3.68	2.72
Long-Term Debt / Total Capital	1.32	1.01	0.72	3.52	2.64
Total Liabilities / Total Assets	7.69	7.02	6.35	9.54	6.86
EBIT / Interest Expense	-244.78	-190.04	-1.2K	13.39K	62.99K
EBITDA / Interest Expense	-142.51	-29.71	1.16K	30.34K	103K
(EBITDA - Capex) / Interest Expense	-164.82	-72.89	494	24.69K	93.75K
Total Debt / EBITDA	-0.57	-2.57	0.73	0.84	0.38
Net Debt / EBITDA	4.48	27.83	-11.73	-3.93	-3.61
Total Debt / (EBITDA - Capex)	-0.49	-1.05	1.72	1.03	0.42
Net Debt / (EBITDA - Capex)	3.87	11.35	-27.49	-4.83	-3.98
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	86.85	35.09	21.76	23.46	16.01
Gross Profit, 1 Yr. Growth %	88.18	34.35	27.29	24.8	20.5
EBITDA, 1 Yr. Growth %	58.54	-66.07	-179.27	1.05K	86.99
EBITA, 1 Yr. Growth %	55.28	-57.28	-116.25	-1.97K	108.86
EBIT, 1 Yr. Growth %	79.88	-30.41	-52.33	-217.29	190.57
Earnings From Cont. Operations, 1 Yr. Growth %	116.46	-51.62	103.51	-132.44	174.89
Net Income, 1 Yr. Growth %	116.46	-51.62	103.51	-132.44	174.89
Normalized Net Income, 1 Yr. Growth %	81.77	-38.73	-73.46	-366.59	156.14
Diluted EPS Before Extra, 1 Yr. Growth %	69.74	-54.09	100.44	-130.27	164.52
Accounts Receivable, 1 Yr. Growth %	124.59	6.17	-8.28	15.22	-4.01
Inventory, 1 Yr. Growth %	141.04	27.34	12.83	34.86	-5.54
Net Property, Plant and Equip., 1 Yr. Growth %	85	-0.9	-0	130.52	-17.36
Total Assets, 1 Yr. Growth %	159.83	-2.64	-3.59	16.6	8.15
Tangible Book Value, 1 Yr. Growth %	-48.16	9.99	23.52	29.83	38.25
Common Equity, 1 Yr. Growth %	160.31	-1.94	-2.89	12.63	11.36
Cash From Operations, 1 Yr. Growth %	225.62	-123.83	486.89	69.82	81.51
Capital Expenditures, 1 Yr. Growth %	89.5	59.02	16.52	13.31	-14.26
Levered Free Cash Flow, 1 Yr. Growth %	-124.15	-54.08	136.61	93.86	37.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-139.46	-53.93	134.83	93.81	37.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	35.04	58.87	28.25	22.61	19.68
Gross Profit, 2 Yr. CAGR %	31.56	59	30.77	26.04	22.63
EBITDA, 2 Yr. CAGR %	89.17	-31.39	-61.2	107.38	340.03
EBITA, 2 Yr. CAGR %	77.02	-23.35	-79.86	60.16	484.64
EBIT, 2 Yr. CAGR %	97.48	7.11	-52.98	-15.62	66.1
Earnings From Cont. Operations, 2 Yr. CAGR %	144.9	2.34	-0.77	-18.75	-5.57
Net Income, 2 Yr. CAGR %	144.9	2.34	-0.77	-18.75	-5.57
Normalized Net Income, 2 Yr. CAGR %	115.92	1.01	-67.11	5.07	142.31
Diluted EPS Before Extra, 2 Yr. CAGR %	101.89	-11.72	-4.07	-22.11	-10.52
Accounts Receivable, 2 Yr. CAGR %	46.46	54.42	-1.31	2.8	5.17
Inventory, 2 Yr. CAGR %	28.42	75.2	19.87	23.35	12.87
Net Property, Plant and Equip., 2 Yr. CAGR %	32.49	35.4	-0.45	51.83	38.02
Total Assets, 2 Yr. CAGR %	107.75	59.05	-3.12	6.03	12.3
Tangible Book Value, 2 Yr. CAGR %	4.04	-24.49	16.56	26.64	33.98
Common Equity, 2 Yr. CAGR %	113.99	59.77	-2.42	4.58	11.99
Cash From Operations, 2 Yr. CAGR %	212.79	-11.91	18.26	215.69	75.57
Capital Expenditures, 2 Yr. CAGR %	39.67	73.59	36.12	14.9	-1.44
Levered Free Cash Flow, 2 Yr. CAGR %	-70.2	241.5	98.09	105.21	59.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	-62.19	262.55	99.7	104.41	59.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.62	35.06	45.39	26.63	20.37
Gross Profit, 3 Yr. CAGR %	35.04	32.48	47.63	28.75	24.17
EBITDA, 3 Yr. CAGR %	26.68	2.04	-28.04	-6.52	93.33
EBITA, 3 Yr. CAGR %	24.6	5.84	-54.32	-13.89	67.51
EBIT, 3 Yr. CAGR %	38.44	35.49	-18.23	-30.88	18.76
Earnings From Cont. Operations, 3 Yr. CAGR %	48.66	42.63	28.69	-31.64	21.98
Net Income, 3 Yr. CAGR %	48.66	42.63	28.69	-31.64	21.98
Normalized Net Income, 3 Yr. CAGR %	36.69	37.81	-35.32	-23.37	34.46
Diluted EPS Before Extra, 3 Yr. CAGR %	21.45	23.23	16.03	-34.69	17.08
Accounts Receivable, 3 Yr. CAGR %	46.57	31.57	29.81	3.92	0.48
Inventory, 3 Yr. CAGR %	48.87	28.06	51.3	24.67	12.86
Net Property, Plant and Equip., 3 Yr. CAGR %	51.59	20.27	22.39	31.7	23.96
Total Assets, 3 Yr. CAGR %	114.33	61.37	34.6	3.05	6.73
Tangible Book Value, 3 Yr. CAGR %	40.73	5.99	-11.03	20.82	30.4
Common Equity, 3 Yr. CAGR %	139.56	64.98	35.33	2.36	6.79
Cash From Operations, 3 Yr. CAGR %	32.74	32.6	65.75	33.42	162.51
Capital Expenditures, 3 Yr. CAGR %	42.09	45.84	51.99	28.05	4.22
Levered Free Cash Flow, 3 Yr. CAGR %	-62.77	62.47	202.26	91.14	76.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	-54.71	68.24	213.76	92.16	76.02
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.53	32.74	31.45	29.93	34.5
Gross Profit, 5 Yr. CAGR %	29.64	45.52	33.31	29.86	37.08
EBITDA, 5 Yr. CAGR %	8.37	-13.21	-13.73	35.47	27.7
EBITA, 5 Yr. CAGR %	8.35	-9.32	-34.69	24.81	22.43
EBIT, 5 Yr. CAGR %	15.42	7.23	-4.21	12.1	13.94
Earnings From Cont. Operations, 5 Yr. CAGR %	19.23	3.35	26.47	13.89	13.71
Net Income, 5 Yr. CAGR %	19.23	3.35	26.47	13.89	13.71
Normalized Net Income, 5 Yr. CAGR %	13.37	1.24	-17.58	23.62	19.91
Diluted EPS Before Extra, 5 Yr. CAGR %	0.46	-10.98	10.52	2.57	4.57
Accounts Receivable, 5 Yr. CAGR %	36.48	28.19	25.12	19.21	19.33
Inventory, 5 Yr. CAGR %	26.43	21.84	36.51	26.16	34.56
Net Property, Plant and Equip., 5 Yr. CAGR %	22.09	26.08	28.12	32.02	28.42
Total Assets, 5 Yr. CAGR %	63.7	71.18	56.01	36.41	25.19
Tangible Book Value, 5 Yr. CAGR %	33.16	54.66	30.51	13.81	4.8
Common Equity, 5 Yr. CAGR %	79.05	95.94	67.26	37.48	25.46
Cash From Operations, 5 Yr. CAGR %	2.48	-20.63	26.74	87.6	69.61
Capital Expenditures, 5 Yr. CAGR %	5.01	37.25	39.67	32.57	27.81
Levered Free Cash Flow, 5 Yr. CAGR %	-57.16	0.18	42.62	78.4	129.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	-53.12	4.08	48.72	81.9	135.05